Results 21 to 30 of about 52,424 (257)

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis [PDF]

BMC Infectious Diseases, 2021
Background Delafloxacin is a novel fluoroquinolone with broad antibacterial activity against pathogens causing acute bacterial skin and skin structure infections (ABSSSI).
Ioanna Vlachaki, Matteo Vacchelli, Daniela Zinzi, Edel Falla, Yilin Jiang, Theo Mantopoulos, Dilip Nathwani   +6 more
doaj   +2 more sources

Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections

Infection and Drug Resistance, 2015
Subhashis Mitra, Usman Saeed, Daniel H Havlichek, Gary E Stein Department of Infectious Diseases, Michigan State University, East Lansing, MI, USA Abstract: Oritavancin, a semisynthetic derivative of the glycopeptide antibiotic chloroeremomycin ...
Mitra S, Saeed U, Havlichek DH, Stein GE
doaj   +1 more source

Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections. [PDF]

J Antimicrob Chemother
Abstract Objectives Lefamulin is a pleuromutilin antibiotic approved for the treatment of community-acquired bacterial pneumonia (CABP). Its spectrum of activity, good penetration into soft tissues and low rates of cross-resistance also make lefamulin a potentially valuable option for treatment of ...
van Os W, Zeitlinger M.
europepmc   +3 more sources

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

Therapeutics and Clinical Risk Management, 2016
Kimberly D Leuthner,1 Kristin A Buechler,1 David Kogan,1 Agafe Saguros,1 H Stephen Lee2 1Department of Pharmaceutical Services, University Medical Center of Southern Nevada, Las Vegas, NV, USA; 2Roseman University of Health Sciences College of Pharmacy,
Leuthner KD, Buechler KA, Kogan D, Saguros A, Lee HS   +4 more
doaj   +1 more source

Clinical outcomes of ceftobiprole in the treatment of acute bacterial skin and skin structure infections

Journal of Global Antimicrobial Resistance, 2021
Guang-Mao Lee, Chien-Ming Chao, Chih-Cheng Lai   +2 more
doaj   +3 more sources

Delafloxacin in Acute Bacterial Skin and Skin Structure Infections. [PDF]

Clin Infect Dis, 2019
Corey GR, McKinnell JA, Rybak MJ.
europepmc   +4 more sources

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections [PDF]

Drug Design, Development and Therapy, 2013
Olatz Urbina,1 Olivia Ferrández,1 Mercè Espona,1 Esther Salas,1 Irene Ferrández,2 Santiago Grau1 1Services of Hospital Pharmacy, Hospital Universitari del Mar, Universitat Autònoma de Barcelona, 2Ciència i Tecnologia ...
Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S   +5 more
doaj   +3 more sources

NIR‐II emissive biohybrid nanovesicles as mild‐temperature photothermal antibiofilm agents against acute bacterial skin and skin‐structure infections

Interdisciplinary Medicine
The emergence of antibiotic‐resistant bacteria poses a significant challenge to the prompt and appropriate treatment of pathogenic bacteria infections, such as acute bacterial skin and skin‐structure infections (ABSSSI), especially in the presence of ...
Ji Wang, Zhihao Wu, Xiaoxi Ma, Zhihui Huang, Haorong Dong, Jinxin Zhang, Xiaoming Liu, Pengfei Zhang, Shuhuai Yao   +8 more
doaj   +2 more sources

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies. [PDF]

Open Forum Infectious Diseases, 2021
George Sakoulas, Anita Das, Evan Tzanis
exaly   +2 more sources

Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections. [PDF]

Drugs, 2020
Scott LJ.
europepmc   +3 more sources